Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Case Report
Authors: Jasthi, D.a | Kollikonda, S.b | Karnati, S.c; *
Affiliations: [a] Case Western Reserve University School of Medicine, Cleveland, OH, USA | [b] Department of Obstetrics and Gynecology, Women’s Health Institute, Cleveland Clinic, Cleveland, OH, USA | [c] Department of Neonatology, Cleveland Clinic Children’s Hospital, Cleveland, OH, USA
Correspondence: [*] Address for correspondence: Sreenivas Karnati, MD, Department of Neonatology, M31, 9500 Euclid Ave, Cleveland, OH 44195, USA. Tel.: +1 216 389 1998; Fax: +1 216 444 7625; E-mail: karnati89@gmail.com.
Abstract: BACKGROUND:Adenosine triphosphate-binding cassette transporter A3 (ABCA3) mutations are recognized as a congenital cause of surfactant deficiency. Clinical presentations of such mutations are largely variable. There are many mutations of the ABCA3 gene, of which, p.E292V is the most common. Despite being the most common ABCA3 gene mutation, there is limited literature on extra pulmonary and long-term outcomes of the affected infants. CASE:We present the case of a Caucasian male infant born at 32 weeks gestation that developed severe respiratory distress shortly after birth, and review published case reports and case series of infants affected with this gene mutation. He was found to have a heterozygous missense mutation p.E292V of ABCA3 resulting in a chronic lung disease. He required multiple courses of systemic and inhalational steroids. He developed supraventricular tachycardia (SVT), feeding problems and hypotonia during his prolonged hospital stay. He demonstrated mild neurodevelopmental delays on follow up at 18 months of age. The chronic lung disease improved over the first 2 years of life. He continued to have feeding difficulties and supraventricular tachycardia at nearly 2 years of age. CONCLUSION:The infant’s SVT may be associated with this ABCA3 variant. Further long-term follow-up studies are needed to better characterize extrapulmonary manifestations of this ABCA3 mutation.
Keywords: BSID III, neurodevelopment, p.E292V, supra ventricular tachycardia
DOI: 10.3233/NPM-210879
Journal: Journal of Neonatal-Perinatal Medicine, vol. 15, no. 3, pp. 653-658, 2022
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl